We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
CURX
226
Curanex Pharmaceuticals
CURX
$6.41M
$6.41M $0.2260 13.1%
CDIO icon
227
Cardio Diagnostics
CDIO
$6.39M
$6.39M $2.16 18%
ENVB icon
228
Enveric Biosciences
ENVB
$6.24M
$6.24M $1.55 0%
ENSC icon
229
Ensysce Biosciences
ENSC
$6.13M
$6.13M $0.3987 5.18%
CLGN icon
230
CollPlant Biotechnologies
CLGN
$6.04M
$6.04M $0.3193 8.24%
NCNA
231
NuCana
NCNA
$5.95M
$5.95M $1.43 0.69%
PMCB icon
232
PharmaCyte Biotech
PMCB
$5.88M
$5.88M $0.5474 0.47%
PULM icon
233
Pulmatrix
PULM
$5.84M
$5.84M – –
SNGX icon
234
Soligenix
SNGX
$5.78M
$5.78M $0.3900 0.91%
BCAB icon
235
BioAtla
BCAB
$5.61M
$5.61M $3.38 3.43%
DRMA icon
236
Dermata Therapeutics
DRMA
$5.55M
$5.55M $1.38 27.8%
BRTX icon
237
BioRestorative Therapies
BRTX
$5.41M
$5.41M $0.2123 1.1%
APVO icon
238
Aptevo Therapeutics
APVO
$5.31M
$5.31M $3.50 15.5%
MLEC icon
239
Moolec Science
MLEC
$5.3M
$5.3M $7.30 3.11%
ERNA icon
240
Eterna Therapeutics
ERNA
$5.16M
$5.16M $4.42 0.68%
HCWB icon
241
HCW Biologics
HCWB
$5.03M
$5.03M $3.15 0.63%
TCRT icon
242
Alaunos Therapeutics
TCRT
$4.88M
$4.88M $2 1.52%
GLMD icon
243
Galmed Pharmaceuticals
GLMD
$4.63M
$4.63M $0.5600 0.56%
MBIO icon
244
Mustang Bio
MBIO
$4.59M
$4.59M $0.6054 0.43%
REVB icon
245
Revelation Biosciences
REVB
$4.34M
$4.34M $1.11 1.77%
LABT
246
Lakewood-Amedex Biotherapeutics
LABT
$4.13M
$4.13M $2.36 0%
ELAB icon
247
Elevai Labs
ELAB
$4.09M
$4.09M $0.9000 0.11%
SILO icon
248
Silo Pharma
SILO
$3.88M
$3.88M $3.10 12.9%
SPRC icon
249
SciSparc
SPRC
$3.78M
$3.78M $6.60 3.23%
GOVX icon
250
GeoVax Labs
GOVX
$3.78M
$3.78M $0.7256 5.77%
7 8 9
10
11

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 273 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $18.3B.

The largest by market cap are Greenwich LifeSciences (GLSI) at $248M, Adagene (ADAG) at $248M and Capricor Therapeutics (CAPR) at $243M.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.